Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1749]

Personalised medicine for rare cancers

Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy

Personalised medicine for rare cancers ( Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy )

Working With Cancer: helping people affected by cancer return to work

Mandy Goodman and Barbara Wilson - Working With Cancer

Working With Cancer: helping people affected by cancer return to work ( Mandy Goodman and Barbara Wilson - Working With Cancer )

Treating the patient, not the disease: in memory of Umberto Veronesi

Prof Gordon McVie - Editor in Chief, ecancer

Treating the patient, not the disease: in memory of Umberto Veronesi ( Prof Gordon McVie - Editor in Chief, ecancer )

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington...

Prevalence of homologous recombination deficiency among 53,000 tumour samples ( Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )

Natural plant based balm antidote to severe nail toxicity during chemotherapy

Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK

Natural plant based balm antidote to severe nail toxicity during chemotherapy ( Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK )

Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers

Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA

Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )

Immunotherapy may slow the growth of malignant pleural mesothelioma

Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France

Immunotherapy may slow the growth of malignant pleural mesothelioma ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )

Targeted sequencing in endocrine refractory breast cancer

Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada

$Targeted sequencing in endocrine refractory breast cancer ( Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada )$

New personalised therapies for lung cancer

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

New personalised therapies for lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )

Findings of a phase I/II study of nivolumab in patients with virus-associated...

Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France

Findings of a phase I/II study of nivolumab in patients with virus-associated tumours ( Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France )

Selumetinib in children with recurrent or refractory low-grade glioma

Dr Jason Fangusaro - Ann & Robert H. Lurie Children's Hospital of Chicago...

$Selumetinib in children with recurrent or refractory low-grade glioma ( Dr Jason Fangusaro - Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, USA )$

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy

Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy ( Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy )

More from ecancer